WHITEHAWK THERAPEUTICS, INC. Convertible Notes Payable, Current
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Convertible Notes Payable, Current of $9.03 million as of 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2022-03-17
- 2020-12-31: Convertible Notes Payable, Current $9.03M.
- 2016-12-31: Convertible Notes Payable, Current $12.39M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2020-12-31 | $9.03M 10-K · filed 2022-03-17 |
| 2016-12-31 | $12.39M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |